» Articles » PMID: 9421496

Zwitterionic Oligodeoxyribonucleotide N3'-->P5' Phosphoramidates: Synthesis and Properties

Overview
Specialty Biochemistry
Date 1998 Feb 28
PMID 9421496
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Zwitterionic, net neutral oligonucleotides containing alternating negatively charged N3'-->P5' phosphoramidate monoester and positively charged phosphoramidate diester groups were synthesized. The ability of zwitterionic phosphoramidates to form complexes with complementary DNA and RNA was evaluated. Stoichiometry and salt dependency of these complexes were determined as a function of the nature of the heterocyclic bases of the zwitterionic compounds. Unlike the melting temperatures of the natural phosphodiester-containing oligomers, the T m of the duplexes formed with the zwitterionic oligothymidylates was salt concentration independent. The thermal stability of these duplexes was much higher with Delta T m values of 20-35 degrees C relatively to phosphodiester counterparts at low salt concentrations. The zwitterionic oligoadenylate formed only 2Py:1Pu triplexes with complementary poly(U) or poly(dT) strands. The thermal stability of these complexes was dependent on salt concentration. Also, the T m values of the complexes formed by the zwitterionic oligoadenylate with poly(U) were 6-41 degrees C higher than for the natural phosphodiester counterpart. Triplexes of this compound with poly(dT) were also more stable with a Delta T m value of 22 degrees C at low salt concentrations. Complexes formed by the zwitterionic oligonucleotides with complementary RNAs were not substrates for RNase H. Surprisingly, the duplex formed by the all anionic alternating N3'-->P5'phosphoramidate-phosphodiester oligothymidylate and poly(A) was a good substrate for RNase H.

Citing Articles

Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology.

Amanat M, Nemeth C, Smith Fine A, Leung D, Fatemi A Pharmaceutics. 2022; 14(11).

PMID: 36365206 PMC: 9695718. DOI: 10.3390/pharmaceutics14112389.


Design, Synthesis, and Properties of Phosphoramidate 2',5'-Linked Branched RNA: Toward the Rational Design of Inhibitors of the RNA Lariat Debranching Enzyme.

Tago N, Katolik A, Clark N, Montemayor E, Seio K, Sekine M J Org Chem. 2015; 80(20):10108-18.

PMID: 26378468 PMC: 4749351. DOI: 10.1021/acs.joc.5b01719.


The spherulites(TM): a promising carrier for oligonucleotide delivery.

Mignet N, Brun A, Degert C, Delord B, Roux D, Helene C Nucleic Acids Res. 2000; 28(16):3134-42.

PMID: 10931929 PMC: 108452. DOI: 10.1093/nar/28.16.3134.

References
1.
Escude C, Giovannangeli C, Sun J, Lloyd D, Chen J, Gryaznov S . Stable triple helices formed by oligonucleotide N3'-->P5' phosphoramidates inhibit transcription elongation. Proc Natl Acad Sci U S A. 1996; 93(9):4365-9. PMC: 39543. DOI: 10.1073/pnas.93.9.4365. View

2.
Dagle J, Weeks D . Positively charged oligonucleotides overcome potassium-mediated inhibition of triplex DNA formation. Nucleic Acids Res. 1996; 24(11):2143-9. PMC: 145908. DOI: 10.1093/nar/24.11.2143. View

3.
Lima W, Crooke S . Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids. Biochemistry. 1997; 36(2):390-8. DOI: 10.1021/bi962230p. View

4.
Heidenreich O, Gryaznov S, Nerenberg M . RNase H-independent antisense activity of oligonucleotide N3 '--> P5 ' phosphoramidates. Nucleic Acids Res. 1997; 25(4):776-80. PMC: 146512. DOI: 10.1093/nar/25.4.776. View

5.
Pless R, Tso P . Duplex formation of a nonionic oligo(deoxythymidylate) analogue (heptadeoxythymidylyl-(3'-5')-deoxythymidine heptaethyl ester (d-(Tp(Et))7T)) with poly(deoxyadenylate). Evaluation of the electrostatic interaction. Biochemistry. 1977; 16(6):1239-50. DOI: 10.1021/bi00625a033. View